Clinical Controversies in Multiple Myeloma

Cleveland Clinic Foundation and the Multiple Myeloma Research Foundation
Last Modified: July 15, 2006

Conference Dates: Friday, September 8, 2006: 8:00AM - 11:00AM
Conference Location: Intercontinental Hotel, 9801 Carengie Avenue, Cleveland, Ohio

Sponsoring Group: Cleveland Clinic Foundation and the Multiple Myeloma Research Foundation

Conference Web Page URL: www.multiplemyeloma.org/medical_programs/index.html?Event=04

Topics Covered:

  • Staging/Prognostic Indicators
  • Frontline Therapy
  • The Role of Stem Cell Transplantation
  • Supportive Care and Bone Disease
  • Novel Therapies and Clinical Trials

Conference Objectives:

  1. Identify the prognostic indicators and diagnostic approaches to multiple myeloma;
  2. Discuss the latest advances in stem cell transplantation, treatment for bone disease, and supportive care management;
  3. Describe the role and appropriate use of novel treatments for multiple myeloma throughout the disease progression.

Who Should Attend: Hematologiests, Medical Oncologists, Oncology Nurses, Internists with recently diagnosed patients

Registration Information: Advanced registration is requested. Registration deadline is Tuesday, September 5, 2006. Register online at: www.clevelandclinicmeded.com/registration.htm. For more information visit: www.multiplemyeloma.org/symposia.

Conference Fees: Free

Continuing Education: Yes

Blogs

Don't Assume You Understand
by Bob Riter
July 29, 2015

Related News

Recommendations Presented for MRI Use in Multiple Myeloma

Feb 3, 2015

MRI is gold standard for imaging axial skeleton, assessing painful lesions, ID'ing benign fractures


ASCO: Elotuzumab Shows Benefit in Multiple Myeloma

Jun 3, 2015

Survival gains when elotuzumab was added to treatment


Lenalidomide Recommended in U.K. for Multiple Myeloma

Jul 30, 2015

Committee finds drug effective for patients who have used at least two other therapies previously